Shares of Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) were up 5.4% during trading on Monday . The company traded as high as $2.80 and last traded at $2.92. Approximately 26,215 shares were traded during trading, a decline of 98% from the average daily volume of 1,144,243 shares. The stock had previously closed at $2.77.
Separately, Zacks Investment Research upgraded shares of Corindus Vascular Robotics from a “sell” rating to a “hold” rating in a research note on Tuesday, May 21st.
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last posted its earnings results on Tuesday, May 7th. The medical equipment provider reported ($0.05) earnings per share for the quarter, hitting the Zacks’ consensus estimate of ($0.05). The firm had revenue of $3.04 million for the quarter, compared to the consensus estimate of $2.90 million.
Institutional investors have recently bought and sold shares of the stock. Jane Street Group LLC bought a new stake in Corindus Vascular Robotics during the 4th quarter worth approximately $36,000. Virtu Financial LLC increased its holdings in shares of Corindus Vascular Robotics by 128.4% in the 1st quarter. Virtu Financial LLC now owns 173,312 shares of the medical equipment provider’s stock worth $301,000 after buying an additional 97,445 shares during the last quarter. Nomura Holdings Inc. increased its holdings in shares of Corindus Vascular Robotics by 18.6% in the 4th quarter. Nomura Holdings Inc. now owns 1,262,445 shares of the medical equipment provider’s stock worth $1,077,000 after buying an additional 198,111 shares during the last quarter. Barclays PLC bought a new position in shares of Corindus Vascular Robotics in the 4th quarter worth $325,000. Finally, Millennium Management LLC increased its holdings in shares of Corindus Vascular Robotics by 1.0% in the 4th quarter. Millennium Management LLC now owns 7,088,692 shares of the medical equipment provider’s stock worth $5,955,000 after buying an additional 68,250 shares during the last quarter.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Modern Readers and is the property of of Modern Readers. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://www.modernreaders.com/news/2019/06/13/corindus-vascular-robotics-nyseamericancvrs-trading-up-5-4.html.
About Corindus Vascular Robotics (NYSEAMERICAN:CVRS)
Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures.
Featured Article: The role of implied volatility with call option volume
Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.